Percutaneous Coronary Intervention and Adjunctive Pharmacotherapy in Women
- 22 February 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 111 (7), 940-953
- https://doi.org/10.1161/01.cir.0000155337.50423.c9
Abstract
More than 1.2 million percutaneous coronary interventions are performed annually in the United States, with only an estimated 33% performed in women, despite the established benefits of percutaneous coronary intervention and adjunctive pharmacotherapy in reducing fatal and nonfatal ischemic complications in acute myocardial infarction and high-risk acute coronary syndromes. This statement reviews sex-specific data on the safety and efficacy of contemporary interventional therapies in women.Keywords
This publication has 99 references indexed in Scilit:
- A Validated Prediction Model for All Forms of Acute Coronary SyndromeJAMA, 2004
- Benefits of direct angioplasty for women and men with acute myocardial infarction: results of the global use of strategies to open occluded arteries in acute coronary syndromes (GUSTO II-B) Angioplasty SubstudyAmerican Heart Journal, 2003
- Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST–elevation myocardial infarction (PRISM-PLUS study)American Heart Journal, 2003
- Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?The American Journal of Cardiology, 2003
- Gender-related changes in the practice and outcomes of percutaneous coronary interventions in northern New England from 1994 to 1999Journal of the American College of Cardiology, 2002
- Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?: Lessons from the ESPRIT studyJournal of the American College of Cardiology, 2002
- One-Year Follow-Up of The Stent Restenosis (STRESS I) StudyThe American Journal of Cardiology, 1998
- Influence of Gender on In-Hospital Clinical and Angiographic Outcomes and on One-Year Follow-Up In the New Approaches to Coronary Intervention (NACI) RegistryThe American Journal of Cardiology, 1997
- Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (Abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarctionThe American Journal of Cardiology, 1996
- Gender differences for coronary angioplastyThe American Journal of Cardiology, 1994